This author has yet to write their bio.Meanwhile lets just say that we are proud Business Wire contributed a whooping 740 entries.
The initiative aims to raise awareness of the role of virtual twins in accelerating medical research and delivering personalized care. On social media, Emma Twin will document how she, as a virtual twin, helps doctors and researchers better understand diseases and the effects of treatments, without risk to real patients.
AWS HealthScribe is a new HIPAA-eligible service that empowers healthcare software providers to build clinical applications that use speech recognition and generative AI to save clinicians time by generating clinical documentation.
Gilead receives the rights to exclusively license EVOQ’s NanoDisc Technology to develop and commercialize immunotherapy products for rheumatoid arthritis and lupus.
Equillium, Inc. and Metacrine, Inc. announced the mutual termination of their previously announced definitive merger agreement.
LEO Pharma A/S, a global leader in medical dermatology, has launched AD Days Around the World, a global disease awareness campaign that highlights the experiences of people living with atopic dermatitis (AD) – the most common form of eczema.
Olohan, formerly Google healthcare managing director, joins the celebrated global health commercialization partner as executive vice president, growth.
The transaction, valued at about $700 million, affirms Alcon’s commitment to the ophthalmic pharmaceutical space and is expected to add broader pharmaceutical R&D capabilities to Alcon’s existing commercial expertise, maximizing the value of its diversified portfolio.
Pending authorization, the Omicron BA.4/BA.5-adapted bivalent vaccine will be available to ship immediately. A conditional marketing authorization application has also been initiated with the European Medicines Agency (EMA) for the Omicron BA.4/BA.5-adapted bivalent vaccine and is expected to be completed in the coming days.
The combined company will operate as Syros Pharmaceuticals and continue to advance Syros’ ongoing clinical programs.
Global health innovation company Real Chemistry announced the acquisition of conversationHEALTH, a conversational artificial intelligence (AI) platform for the health care and life sciences industry.
